These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 12390145
21. Latanoprost versus combined timolol and dorzolamide. Bron AM, Emmerich KH. Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S148-54. PubMed ID: 12204712 [Abstract] [Full Text] [Related]
22. Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma. D'Andrea A, D'Andrea D, Ferreri G. Acta Ophthalmol Scand Suppl; 1998 Aug; (227):36-8. PubMed ID: 9972339 [Abstract] [Full Text] [Related]
23. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group. Clineschmidt CM, Williams RD, Snyder E, Adamsons IA. Ophthalmology; 1998 Oct; 105(10):1952-9. PubMed ID: 9787369 [Abstract] [Full Text] [Related]
24. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Clineschmidt CM, Williams RD, Snyder E, Adamsons IA. Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693 [Abstract] [Full Text] [Related]
25. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Strohmaier K, Snyder E, DuBiner H, Adamsons I. Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691 [Abstract] [Full Text] [Related]
26. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group. Strohmaier K, Snyder E, DuBiner H, Adamsons I. Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367 [Abstract] [Full Text] [Related]
27. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T. J Glaucoma; 2009 Oct; 18(4):293-300. PubMed ID: 19365194 [Abstract] [Full Text] [Related]
28. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. Strahlman ER, Vogel R, Tipping R, Clineschmidt CM. Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800 [Abstract] [Full Text] [Related]
29. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Konstas AG, Maltezos A, Bufidis T, Hudgins AG, Stewart WC. Eye (Lond); 2000 Feb; 14 ( Pt 1)():73-7. PubMed ID: 10755105 [Abstract] [Full Text] [Related]
30. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC. Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169 [Abstract] [Full Text] [Related]
31. Additive effect of latanoprost to the combination of timolol and dorzolamide. Susanna R, Nicolela MT, Oga E. J Glaucoma; 2000 Apr; 9(2):183-6. PubMed ID: 10782630 [Abstract] [Full Text] [Related]
32. [Glaucoma: an ocular blood flow disorder?]. Recker K. Ophthalmologe; 2003 Feb; 100(2):2 p following 174. PubMed ID: 12650170 [No Abstract] [Full Text] [Related]
33. Additive effect of dorzolamide on aqueous humor flow in patients receiving long-term treatment with timolol. Wayman LL, Larsson LI, Maus TL, Brubaker RF. Arch Ophthalmol; 1998 Nov; 116(11):1438-40. PubMed ID: 9823342 [Abstract] [Full Text] [Related]
34. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices. Gugleta K, Orgül S, Flammer J. Curr Med Res Opin; 2003 Nov; 19(4):330-5. PubMed ID: 12841926 [Abstract] [Full Text] [Related]
35. A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma. Siesky B, Harris A, Sines D, Rechtman E, Malinovsky VE, McCranor L, Yung CW, Zalish M. J Ocul Pharmacol Ther; 2006 Oct; 22(5):353-61. PubMed ID: 17076630 [Abstract] [Full Text] [Related]
36. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study. Simpson AJ, Gray TB, Ballantyne C. Aust N Z J Ophthalmol; 1996 Feb; 24(1):39-42. PubMed ID: 8743003 [Abstract] [Full Text] [Related]
37. The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension. Hartenbaum D. Clin Ther; 1996 Feb; 18(3):460-5. PubMed ID: 8829021 [Abstract] [Full Text] [Related]
38. [Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors]. Herkel U, Pfeiffer N. Ophthalmologe; 2001 Oct; 98(10):929-33. PubMed ID: 11699313 [Abstract] [Full Text] [Related]
39. Comparison of the efficacy of the fixed-combination timolol/dorzolamide versus concomitant administration of timolol and dorzolamide. Bacharach J, Delgado MF, Iwach AG. J Ocul Pharmacol Ther; 2003 Apr; 19(2):93-6. PubMed ID: 12804053 [Abstract] [Full Text] [Related]
40. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group. Sverrisson T, Gross R, Pearson J, Rusk C, Adamsons I. J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]